Paper Details

  1. Home
  2. Paper Details

[Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)].

Author: NoskovaK K, Vasil'evIu V, ZelenikinS A

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study investigated the efficacy and safety of rabeprazole, a proton pump inhibitor, in treating gastroesophageal reflux disease (GERD). Rabeprazole (20 mg/day) showed a 100% efficacy rate in healing erosions and diffuse pathological changes of the esophagus mucous in 90% of patients within 4 weeks. Rabeprazole was well tolerated, with few and insignificant side effects.
Paper Details　
Original Abstract of the Article :
The results on estimation of efficiency and safety of monotherapy by Rabeprasol in dose 20 mg per day in treatment of the gastroesophageal reflux disease in an open clinical investigation are presented. It was found 100% of Rabeprasol efficiency in healing of erosion and diffuse pathological changes...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/12271586

データ提供：米国国立医学図書館（NLM）

Rabeprazole: A Healing Oasis for Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD), a condition that causes stomach acid to back up into the esophagus, can feel like a burning desert in your chest. This study investigates the effectiveness of rabeprazole (Pariet) in treating GERD at the reflux-esophagitis stage. The researchers conducted an open clinical investigation to assess the efficacy and safety of rabeprazole monotherapy in patients with GERD.

Rabeprazole: A Potential Solution for GERD

The study found that rabeprazole demonstrated high efficacy in healing erosions and pathological changes in the esophageal mucosa. In 90% of patients, healing occurred within four weeks of treatment, with complete healing observed within eight weeks in all patients. This suggests that rabeprazole may be a valuable treatment option for patients with GERD at the reflux-esophagitis stage.

A Camel's Advice: Seek Relief from GERD

If you're experiencing the discomfort of GERD, it's essential to seek medical advice and explore potential treatment options. This study suggests that rabeprazole may offer a path to healing and relief. Remember, the desert of GERD can be a challenging journey, but there are oases of relief waiting to be discovered.

Dr. Camel's Conclusion

This research highlights the effectiveness of rabeprazole in treating GERD. The high efficacy and safety profile of this medication offer a potential oasis for patients struggling with the discomfort of this condition. Remember, seeking expert guidance is crucial in navigating the complexities of GERD and finding the most suitable treatment path for you.

Date :
  1. Date Completed 2002-11-20
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

12271586

DOI: Digital Object Identifier

12271586

Related Literature

Article Analysis
・Side Effects of rabeprazole
SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.